The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...
U.K. researchers at Nottingham Trent University, the University of Southampton and University Hospital Southampton and product development company Zelemiq Ltd. developed a wearable sensor that ...